Atlas Trials

Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis

Clinical trial NCT04261023 · TERMINATED

Trial details

NCT number
NCT04261023
Sponsor
University of Leeds
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Inflammatory Arthritis
Start date
2020-02-24
Primary completion
2021-03-15
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.